The objectives of the Administrative and Statistical Core are to provide overall administrative direction for all aspects of the PPG proposal. The services will include the following: 1. To assist in the biostatistical design of experiments in all of the projects with respect to sample size and potential differences between groups. 2. To assist in the biostatistical analysis of laboratory data, particularly where large amounts of information are generated per individual analyzed (e.g. proteomics and genomics data). 3. Facilitate optimal interactions among all projects and cores. 4. Facilitate communication and collaboration among all projects and with other cores both within the PPG and in the Comprehensive Cancer Center. 5. To coordinate meetings and communication among the Exectutive Committee members at the University of Michigan and University of Loyola. 6. To coordinate and facilitate the input of members of the Intemal and External Advisory Board, including meetings and travel arrangements. 7. Coordinate travel arrangements for PPG investigators and External Advisiory Board Members. 8. Provide administrative support to the investigators, including secretarial, personnel management, and document generation. 9. To manage all financial aspects of the grant. 10. To work with internal and external institutions and agencies (University of Michigan, University of Loyola, and the NIH) to ensure appropriate administrative documentation, communication, and accountability.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA039542-18
Application #
6989626
Study Section
Subcommittee G - Education (NCI)
Project Start
2004-09-24
Project End
2009-06-30
Budget Start
2004-09-24
Budget End
2005-06-30
Support Year
18
Fiscal Year
2004
Total Cost
$76,910
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Holtan, Shernan G; DeFor, Todd E; Panoskaltsis-Mortari, Angela et al. (2018) Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802. Blood Adv 2:1882-1888
Ortiz-Velez, Laura; Ortiz-Villalobos, Javiera; Schulman, Abby et al. (2018) Genome alterations associated with improved transformation efficiency in Lactobacillus reuteri. Microb Cell Fact 17:138
Ferrara, James L M; Chaudhry, Mohammed S (2018) GVHD: biology matters. Hematology Am Soc Hematol Educ Program 2018:221-227
Major-Monfried, Hannah; Renteria, Anne S; Pawarode, Attaphol et al. (2018) MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD. Blood 131:2846-2855
Naymagon, Steven; Naymagon, Leonard; Wong, Serre-Yu et al. (2017) Acute graft-versus-host disease of the gut: considerations for the gastroenterologist. Nat Rev Gastroenterol Hepatol 14:711-726
Hartwell, Matthew J; Ă–zbek, Umut; Holler, Ernst et al. (2017) An early-biomarker algorithm predicts lethal graft-versus-host disease and survival. JCI Insight 2:e89798
Stickel, N; Hanke, K; Marschner, D et al. (2017) MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantation. Leukemia 31:2732-2741
Ferrara, James Lm; Smith, Christopher M; Sheets, Julia et al. (2017) Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis. J Clin Invest 127:2441-2451
Miller, Holly K; Braun, Thomas M; Stillwell, Terri et al. (2017) Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant 23:522-528
Renteria, Anne S; Levine, John E; Ferrara, James L M (2016) Therapeutic targets and emerging treatment options in gastrointestinal acute graft-versus-host disease. Expert Opin Orphan Drugs 4:469-484

Showing the most recent 10 out of 231 publications